Craig Thompson

2.1k total citations
17 papers, 324 citations indexed

About

Craig Thompson is a scholar working on Epidemiology, Infectious Diseases and Modeling and Simulation. According to data from OpenAlex, Craig Thompson has authored 17 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Infectious Diseases and 3 papers in Modeling and Simulation. Recurrent topics in Craig Thompson's work include Influenza Virus Research Studies (10 papers), Respiratory viral infections research (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Craig Thompson is often cited by papers focused on Influenza Virus Research Studies (10 papers), Respiratory viral infections research (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Craig Thompson collaborates with scholars based in United Kingdom, Israel and Austria. Craig Thompson's co-authors include Nigel Temperton, Keith Grehan, Uri Obolski, George Carnell, Sunetra Gupta, Robin N. Thompson, Francesca Ferrara, Teresa Lambe, Sarah C. Gilbert and José Lourenço and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Scientific Reports.

In The Last Decade

Craig Thompson

16 papers receiving 318 citations

Peers

Countries citing papers authored by Craig Thompson

Since Specialization

Citations

This map shows the geographic impact of Craig Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Thompson more than expected).

Fields of papers citing papers by Craig Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Thompson. The network helps show where Craig Thompson may publish in the future.

Co-authorship network of co-authors of Craig Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Thompson. A scholar is included among the top collaborators of Craig Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Thompson. Craig Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	How Broadly Neutralising Antibodies Are Redefining Immunity to Influenza 2025 ·Antibodies ·(unknown), (unknown), Craig Thompson	1
2	Serological analysis in humans in Malaysian Borneo suggests prior exposure to H5 avian influenza near migratory shorebird habitats 2024 ·Nature Communications ·(unknown), Timothy William, Jack Mellors, (unknown), Giri Shan Rajahram, Tock H. Chua, (unknown), (unknown), (unknown), Mohammad Saffree Jeffree, Nigel Temperton, Tom Tipton, Craig Thompson, Kamruddin Ahmed, Chris Drakeley, Miles W. Carroll, Kimberly Fornace	2
3	The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants 2023 ·Frontiers in Immunology ·Robin N. Thompson, (unknown), (unknown), (unknown), Shingo Iwami, Craig Thompson, Uri Obolski	12
4	Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents 2023 ·Frontiers in Immunology ·(unknown), Emily Adland, Anna Csala, Nicholas Lim, Stephanie Longet, Ane Ogbe, Jeremy Ratcliff, Oliver Sampson, Craig Thompson, Lance Turtle, Eleanor Barnes, Susanna Dunachie, Paul Klenerman, Miles W. Carroll, Philip Goulder	6
5	Prevalence and duration of anti-SARS-CoV-2 antibodies in healthcare workers. 2022 ·PubMed ·Caroline Klint Johannesen, (unknown), Maria Elisabeth Lendorf, (unknown), (unknown), Robert S. Paton, Craig Thompson, Stig Mølsted, (unknown), (unknown), Cecilie Bo Hansen, Ellen Løkkegaard, Thomas Christensen, (unknown), Thea Kølsen Fischer	2
6	Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies 2021 ·Frontiers in Immunology ·Francesca Ferrara, (unknown), (unknown), (unknown), Simon D. Scott, Sasan Fereidouni, Craig Thompson, Paul Kellam, Sarah C. Gilbert, George Carnell, Nigel Temperton	9
7	An Antigenic Thrift-Based Approach to Influenza Vaccine Design 2021 ·Vaccines ·Jai S. Bolton, (unknown), Judith Wellens, Matthew Edmans, Uri Obolski, Craig Thompson	7
8	Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies. 2021 ·Apollo (University of Cambridge) ·Francesca Ferrara, (unknown), (unknown), (unknown), Simon D. Scott, Sasan Fereidouni, Craig Thompson, Paul Kellam, Sarah C. Gilbert, George Carnell, Nigel Temperton	0
9	Real-time seroprevalence and exposure levels of emerging pathogens in infection-naive host populations 2021 ·Scientific Reports ·Francesco Pinotti, Uri Obolski, Paul S. Wikramaratna, Marta Giovanetti, Robert S. Paton, Paul Klenerman, Craig Thompson, Sunetra Gupta, José Lourenço	2
10	Production, titration, neutralisation and storage of SARS-CoV-2 lentiviral pseudotypes 2020 ·Figshare ·Cecilia Di Genova, (unknown), (unknown), Diego Cantoni, Martin Mayora Neto, Emma Bentley, Giada Mattiuzzo, Edward Wright, (unknown), (unknown), (unknown), (unknown), Mohamed A. Said, (unknown), Elinor Thompson, Craig Thompson, George Carnell, Nigel Temperton	5
11	Increased frequency of travel in the presence of cross-immunity may act to decrease the chance of a global pandemic 2019 ·Philosophical Transactions of the Royal Society B Biological Sciences ·Robin N. Thompson, Craig Thompson, (unknown), Sunetra Gupta, Uri Obolski	24
12	Identifying genes associated with invasive disease in S. pneumoniae by applying a machine learning approach to whole genome sequence typing data 2019 ·Scientific Reports ·Uri Obolski, Andrea Gori, José Lourenço, Craig Thompson, Robin N. Thompson, Neil French, Robert S. Heyderman, Sunetra Gupta	16
13	A naturally protective epitope of limited variability as an influenza vaccine target 2018 ·Nature Communications ·Craig Thompson, José Lourenço, Adam A. Walters, Uri Obolski, Matthew Edmans, Duncan S. Palmer, Kreepa Kooblall, George Carnell, Daniel O’Connor, Thomas A. Bowden, Oliver G. Pybus, Andrew J. Pollard, Nigel Temperton, Teresa Lambe, Sarah C. Gilbert, Sunetra Gupta	29
14	Influenza vaccination and the ‘diversity paradox’ 2018 ·Human Vaccines & Immunotherapeutics ·Craig Thompson, Uri Obolski	2
15	Vaccination can drive an increase in frequencies of antibiotic resistance among nonvaccine serotypes ofStreptococcus pneumoniae 2018 ·Proceedings of the National Academy of Sciences ·Uri Obolski, José Lourenço, Craig Thompson, Robin N. Thompson, Andrea Gori, Sunetra Gupta	35
16	ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice 2017 ·Vaccine ·Naif Khalaf Alharbi, Eriko Padron-Regalado, Craig Thompson, Alexandra Kupke, Daniel Wells, (unknown), Keith Grehan, Nigel Temperton, Teresa Lambe, George M. Warimwe, Stephan Becker, Adrian V. S. Hill, Sarah C. Gilbert	113
17	Pseudotype-Based Neutralization Assays for Influenza: A Systematic Analysis 2015 ·Frontiers in Immunology ·George Carnell, Francesca Ferrara, Keith Grehan, Craig Thompson, Nigel Temperton	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact